Inspire Medical Systems (INSP) Profit After Tax Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 4.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 125.69% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.30% |
| 10 | Inspire Medical Systems | 1.17 Bn | 889.44 Mn | 176.91 Mn | -477.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -477.47% |
| Dec 31, 2025 | 286.36% |
| Sep 30, 2025 | -46.30% |
| Jun 30, 2025 | -136.68% |
| Mar 31, 2025 | 129.91% |
| Dec 31, 2024 | 138.60% |
| Sep 30, 2024 | 316.59% |
| Jun 30, 2024 | 181.94% |
| Mar 31, 2024 | 35.13% |
| Dec 31, 2023 | 368.67% |
| Sep 30, 2023 | 49.31% |
| Jun 30, 2023 | 17.52% |
| Mar 31, 2023 | 7.61% |
| Dec 31, 2022 | 231.74% |
| Sep 30, 2022 | -62.82% |
| Jun 30, 2022 | -10.71% |
| Mar 31, 2022 | -2.95% |
| Dec 31, 2021 | 68.05% |
| Sep 30, 2021 | 0.37% |
| Jun 30, 2021 | 43.31% |
| Mar 31, 2021 | 0.18% |
| Dec 31, 2020 | 17.58% |
| Sep 30, 2020 | -25.92% |
| Jun 30, 2020 | -201.82% |
| Mar 31, 2020 | -96.53% |
| Dec 31, 2019 | -90.04% |
| Sep 30, 2019 | -75.73% |
| Jun 30, 2019 | -30.64% |
| Mar 31, 2019 | -27.15% |
| Dec 31, 2018 | -12.37% |
| Sep 30, 2018 | -16.68% |
| Jun 30, 2018 | -23.13% |
| Mar 31, 2018 | -45.08% |